Might also be some short covering in to year end. In October all of my holdings were lent out, in late October and early November there had been significant covering but about 25% of my shares have remained on borrow. Or maybe we will get a positive Aducanumab decision overnight, although I would have expected Eisai would also have moved if that were the case.
Putting numbers on it, page-47
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.040(4.21%) |
Mkt cap ! $171.0M | |||
| Open | High | Low | Value | Volume |
| 96.0¢ | $1.01 | 96.0¢ | $185.2K | 189.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46969 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 8272 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CGS (ASX) Chart |